UnitedHealth’s bid for DaVita Medical gets conditional FTC approval
Category: #health  By Mateen Dalal  Date: 2019-06-21
  • share
  • Twitter
  • Facebook
  • LinkedIn

UnitedHealth’s bid for DaVita Medical gets conditional FTC approval

Within forty days of closure of the acquisition, UnitedHealth Group would divest DaVita Medical Group’s healthcare provider in Las Vegas

UnitedHealth Group has reportedly been granted approval by the Federal Trade Commission for its $4.3 billion acquisition of DaVita Medical Group from DaVita Inc., following a lengthy regulatory procedure due to certain concerns regarding a monopoly in Las Vegas.

Apparently, the deal has had closer inspection from regulators than predicted. FTC's approval, announced on the afternoon of June 19, 2019, came with conditions including divestitures of a Las Vegas health plan network under a consent order with the government and a proposed antitrust settlement.

The FTC has stated that within forty days of closure of the acquisition, UnitedHealth Group would divest DaVita Medical Group’s healthcare provider agency in Las Vegas, called HealthCare Partners of Nevada, to Utah-based healthcare provider Intermountain HealthCare. The FTC seemed worried about a monopoly in Las Vegas, stating that UnitedHealth's Optum providers and operations under the ownership of DaVita would have ruled majority of the market.

According to reports, UnitedHealth’s Optum confirmed the acquisition and announced that DaVita’s high-quality practices in Washington, Florida, California, Colorado and New Mexico are now under OptumCare.

Andrew Witty, CEO, Optum, was reportedly quoted saying that it was an important step in building a next-gen healthcare organization and improving patient healthcare experiences while lowering costs across the entire range of healthcare services, including primary, specialty, urgent, and surgical care.

For the uninitiated, DaVita Medical Group is a subsidiary of DaVita Inc., which is an major provider of dialysis and kidney care services. UnitedHealth will not be possessing DaVita’s kidney care centers. The range of DaVita operations sold to Optum include centers for surgery and urgent care, along with medical clinics governed by both primary care doctors and specialists.  

UnitedHealth Group is a Minnesota-based managed health care brand that offers health care products and insurance services. The brand Optum was established in 2011 in order to affiliate the company's healthcare services business.

 

Source credit: https://www.forbes.com/sites/brucejapsen/2019/06/19/unitedhealth-group-wins-ftc-approval-of-davita-deal/#49797f846e40

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
By Mateen Dalal

Air France–KLM S.A., one of the leading global air transport players, has reportedly made a proposal to invest in Malaysia Airlines and gain around 49 percent stake. Japan Airlines (JAL) is also looking to acquire a 25 percent stake in Mal...

Accenture opens innovation center in South Beach Road office
Accenture opens innovation center in South Beach Road office
By Mateen Dalal

Accenture, an Irish multinational professional services company, has recently opened a global innovation center within the Accenture’s office at South Beach Road, which is supported by EDB (Economic Development Board) in Singapore. It will pro...

Verrica unveils positive data from VP-102 study in molluscum treatment
Verrica unveils positive data from VP-102 study in molluscum treatment
By Mateen Dalal

Findings from the study are being produced at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast The data indicated a considerable increase in the percentage of patients with lesion clearance in VP-102 group Verrica Pharmaceu...